Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × INDIV × Lung Neoplasms × Clear all

Phase

Status

Sponsor Class

OTHER 564 INDUSTRY 161 NIH 66 NETWORK 53 OTHER_GOV 16 UNKNOWN 2 INDIV 1 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Lipoma 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Osteosarcoma 1 Neutropenia 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Liver Neoplasms 1 Esophageal Neoplasms 1 Cancer Cachexia 1 Breast Neoplasms 1 Barrett Esophagus 1 Anemia 1

Interventions

pegfilgrastim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00050674 2012-12-27

Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma

Schwartzberg, Lee, M.D.

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡